Advertisement

Topics

Commentary: Glybera- When the experts disagree

06:37 EST 9 Nov 2011 |

Published with kind permission of MEDNOUS. The Committee for Advanced Therapies (CAT) was set up at the European Medicines Agency in 2009 in order to give expert advice on whether advanced therapy medicinal products should be approved or not. These therapies include gene and cell therapies and products engineered from human and/or animal tissue. The [...]

Original Article: Commentary: Glybera- When the experts disagree

NEXT ARTICLE

More From BioPortfolio on "Commentary: Glybera- When the experts disagree"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...